Screening for Prostate Cancer: Sharing the Decision Slide Set
Online Slide Presentation

		Terms of Use This CDC slide set is in the public domain. You may reproduce these slides without permission as long as they are not changed in any way. However, if you wish to adapt and/or revise these slides, you must remove the CDC name, logo, and any other references prior to use. Failure to follow these procedures could result in legal action.

Index View | Thumbnail View

1. Screening for Prostate Cancer: Sharing the Decision
2. These Organizations Recommend a Form of Shared Decision Making for Prostate Cancer Screening
3. Today’s Goals
4. Goal 1
5. Risk of Prostate Cancer in 40 year old U.S. men, to End of Life (per 1,000 men)
6. Risk of Death for 40 year old U.S. Men, to End of Life, by Leading Causes
7. Prostate Cancer Trends in Incidence and Mortality, 1973–1999
8. Risk of Death From Prostate Cancer by Age and by Race/Ethnicity
9. Risk of Prostate Cancer Diagnosis by Age and by Race/Ethnicity
10. Natural History of Prostate Cancer
11. Prostate Cancers Vary in Their Natural Histories
12. Preventing Prostate Cancer
13. Summary

14. Goal 2
    15. Key Issues of Screening and Early Treatment
    16. What Are the Potential Benefits of Screening?
    17. Prostate Cancer Incidence Rates by Stage, 1973–1995
    18. Finding Prostate Cancer Earlier Is Not Enough
    19. Can We Treat Early-Stage Prostate Cancer Effectively?
    20. Risk of Mortality From Prostate Cancer Among Men in a Randomized Trial
    21. What Happened to U.S. Prostate Cancer Mortality Rates as Screening Rates Increased?
    22. What Happens to Prostate Cancer Mortality Rates in the U.K., where PSA Screening Is Rare?
    23. Do We Extend Men’s Lives by Screening for Prostate Cancer?
    24. Are There Harms From Screening and Early Treatment?
    25. Harms: False Positives
    26. Overdiagnosis
    27. Overdiagnosis, Tumor Heterogeneity, and Life Expectancy
    28. Overdiagnosis
    29. Tumor Rates by Grade
    30. Side Effects of Treatment

31. Summary
32. How Can I Decide Whether to Screen My Patients?
33. Should I Screen Higher-Risk Patients?
34. Goal 3
35. Informing Patients
36. Adding Shared Decision Making
37. Shared Decision Making for Other Clinical Decisions
38. Benefits of Shared Decision Making
39. What Is the Best Way To Use Shared Decision Making?
40. Inform Your Patient
41. Decision Aids To Help in Shared Decision Making
42. Decision Aids To Help in Shared Decision Making
43. Discuss His Questions and Concerns
44. Discuss Why Men Choose Different Options
45. Listen and Make a Joint Decision
46. Summary
47. CDC Activities and Resources Related to Prostate Cancer and Shared Decision Making

Top of Page

Privacy Policy | Accessibility

Cancer Home | About DCPC | Events | En Espaρol | Site Map | Contact Us

CDC Home | Search | Health Topics A-Z

Page last reviewed: Monday, November 15, 2004

United States Department of Health and Human Services
Centers for Disease Control and Prevention
National Center for Chronic Disease Prevention and Health Promotion
Division of Cancer Prevention and Control